Related Experiment Video

Updated: Aug 29, 2026

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion

X Wu1, T Obata, Q Khan

  • 1UC Davis Cancer Center, Sacramento, CA, USA.

BJU International
|December 18, 2003
PubMed
Abstract

Insights

The phosphatidylinositol 3-kinase (PI-3K) pathway is crucial for bladder cancer cell invasion. Inhibiting this pathway significantly reduced cancer cell invasiveness, and over half of primary bladder tumors showed high pathway activation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The phosphatidylinositol 3-kinase (PI-3K) pathway plays a critical role in cellular processes.
  • Aberrant activation of the PI-3K pathway is implicated in various cancers, including bladder cancer.

Purpose of the Study:

  • To investigate the role of the PI-3K pathway in bladder cancer cell invasion.
  • To assess PI-3K pathway activation in primary human bladder tumors.

Main Methods:

  • Bladder cancer cell lines were treated with PI-3K pathway inhibitors or transfected with pathway components.
  • Invasion assays were used to analyze cell invasiveness.
  • Western blotting was employed to detect pathway activation in cell lines and primary tumors.

Main Results:

  • The PI-3K inhibitor Ly294002 significantly suppressed the invasion of highly invasive bladder cancer cell lines.
  • Restoring PTEN or expressing dominant-negative Akt inhibited invasion, confirming the PI-3K/Akt pathway's central role.
  • 55% of primary bladder tumors exhibited high levels of phosphorylated Akt, indicating pathway activation.

Conclusions:

  • Inhibiting the PI-3K pathway drastically reduced bladder cancer cell invasiveness.
  • High Akt phosphorylation in over half of primary bladder tumors suggests aberrant PI-3K pathway activation contributes to invasion in a significant subset of bladder cancers.

More Related Videos

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model

Published on: June 11, 2014

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...